Olaplex (OLPX) Q4 2024 earnings summary

Executive summary

• 2024 was a year of transformation, with strategic focus on innovation, marketing, and operational excellence, and key leadership hires.

• Q4 2024 net sales declined 9.8% year-over-year to $100.7M, with full-year net sales at $422.7M, and net income turning negative.

• Adjusted EBITDA for Q4 was $17.5M (17.4% margin), and for FY 2024 was $129.7M (30.7% margin).

• Ended the year with a strong holiday season and better-than-expected performance in key channels.

• Transformation priorities included maximizing sales, marketing, and education investments, and developing a long-term roadmap.

Financial highlights

• Q4 2024 net sales: $100.7M, down 9.8% year-over-year; FY 2024 net sales: $422.7M, down 7.8%.

• Q4 adjusted EBITDA: $17.5M (17.4% margin), down from $36.0M (32.2%) in Q4 2023.

• Q4 adjusted net income: $7.6M vs $22.3M prior year; adjusted diluted EPS: $0.01 vs $0.03.

• Year-end cash and equivalents: $586M, up $120M from 2023; inventory reduced to $75.2M from $95.9M.

• Long-term debt at year-end: $643.7M, slightly down from $649.0M.

Outlook and guidance

• FY 2025 net sales expected between $410M and $431M, representing -3% to +2% change from FY 2024.

• Adjusted gross profit margin guidance: 70.5%-71.5%; adjusted EBITDA margin: 20%-22%.

• Q1 2025 net sales anticipated to be below full-year run rate, with growth expected to build through the year.

• North America expected to lead growth, with international performance moderated by ongoing transformation.

• Continued investment in R&D, marketing, and talent to drive demand and innovation.